ACO Group has gone into a collaboration with Prima Nexus to distribute rapid covid19 rapid test kits! The company announced this surprisng news after the market closed just now. And most importantly, they have gotten approval from Ministry of Health Malaysia.

Under the business collaboration agreement, ACO Group and Prima Nexus will work together to distribute theMOH-approved Covid-19 Antibody Rapid Test Kit within Malaysia. ACO Group will be able to leverage on its existing distribution channels to distribute the on-demand test kits.

Blood samples from individuals will be taken by finger-pricking and this easy-to-use test kit can generate results on-site within 15 minutes, with no requirement for samples to be sent to external diagnostic laboratories. The tests will be carried out under the supervision of medical professionals from Prima Nexus who will also certify the results.

As we have been seeing a great rally supported by the health and medical theme in the past 2 months, it looks like ACO Group is likely to ride on the rally to breakout its IPO price of 28 cents soon. Listed at the worst time back in march, a late rally to reward its IPO shareholders is now in sight amid recent developments and its solid fundamental.